Madison El-Saadi
Stock Analyst at B. Riley Securities
(2.91)
# 1,233
Out of 5,113 analysts
13
Total ratings
46.15%
Success rate
14.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $65.58 | +54.01% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $7.69 | +82.05% | 2 | Dec 31, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $21 → $50 | $21.57 | +131.80% | 2 | Dec 15, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $12.73 | +190.65% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $185.17 | -3.33% | 1 | Oct 1, 2025 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $24 → $26 | $14.76 | +76.15% | 3 | May 16, 2025 |
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $65.58
Upside: +54.01%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.69
Upside: +82.05%
Capricor Therapeutics
Dec 15, 2025
Reiterates: Buy
Price Target: $21 → $50
Current: $21.57
Upside: +131.80%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $12.73
Upside: +190.65%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $185.17
Upside: -3.33%
Eton Pharmaceuticals
May 16, 2025
Reiterates: Buy
Price Target: $24 → $26
Current: $14.76
Upside: +76.15%